ANI Pharmaceuticals, Inc. (BST:BSFA)

Market Cap	1.14B
Revenue (ttm)	623.65M
Net Income (ttm)	-20.75M
Shares Out	n/a
EPS (ttm)	-1.07
PE Ratio	n/a
Forward PE	10.41
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	55.50
Previous Close	55.50
Day's Range	55.50 - 55.50
52-Week Range	47.80 - 63.50
Beta	n/a
RSI	53.65
Earnings Date	Aug 7, 2025

About ANI Pharmaceuticals

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group pu...

• Industry: Pharmaceutical Preparations
• Founded: 2001
• Employees: 897
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: BSFA

Financial Performance

Financial numbers in USD